ORTEXORTEX News
Tracking EXTR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EX
Earnings PreviewEXTR

EXTR Short Interest Hits Yearly Low Before Tuesday's Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 2 Nov 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short interest in Extreme Networks has dropped to its lowest level in at least a year, with shorts covering at a pace running 1.6 standard deviations below the company's typical weekly move. That is the single most consequential positioning shift ahead of Tuesday's results.

The retreat is substantial. Shares short have fallen from roughly 8.1 million in late September to 5.7 million now, a 31% decline in five weeks. Short interest as a percentage of the free float is down to 4.3%. The week-on-week drop alone is 12.4%. Cost to borrow has followed, slipping to 0.41% after falling more than a third on the week. Borrow availability remains exceptionally loose, with far more shares available in the lending pool than are currently shorted. Nothing in the lending market suggests squeeze pressure or renewed short conviction.

The stock gained 2.9% over the past week, outpacing the median of its closest peers, which was flat over the same period. CSCO fell 1.9% on the week and NTCT dropped 3.3%, while SILC shed more than 12%. EXTR's relative strength stands out in a group that broadly underperformed.

Options add a minor note of caution without undermining the covering narrative. The put/call ratio edged to 0.31, about one standard deviation above its 20-day average. That is a mild tilt toward protection rather than a crowded defensive stance. The 52-week range on the PCR runs from 0.09 to 0.84, so the current level sits well within normal bounds.

Analysts covering the stock are uniformly constructive. Rosenblatt maintained its Buy rating and $38 target as recently as October 29. Needham reiterated Buy at $35 the day before. The consensus mean target is $33.63 against a current price of $22.61, implying substantial upside on the Street's numbers. The bull case rests on Q4 revenue of $339 million, up 10% year over year, a ninth straight quarter of sequential product revenue growth, and management's FY27 growth guidance of 8% to 9%, with SaaS ARR reaching $244 million. Bears point to customer concentration risk: three customers represented 59% of revenue in FY2024, and macro-driven spending caution could pressure margins faster than product-cycle tailwinds can offset.

One ownership move is worth noting. BlackRock filed an amended 13G on October 27, disclosing a 15.3% stake of 20.2 million shares. T. Rowe Price added more than 5 million shares in the latest reported quarter, pushing its holding to just over 4% of shares outstanding. These are passive disclosures, not activist positions, but the direction of flow from two large institutions adds a constructive backdrop to the covering narrative.

Tuesday's report will test whether the fundamental momentum behind Q4's beat, particularly the AI-driven enterprise refresh and Platform ONE adoption, has translated into a durable revenue trajectory for FY27, or whether the macro caution flagged by the bear case has begun to show in bookings and pipeline.

Stocks in this article

See the live data behind this article on ORTEX.

Open EXTR on ORTEX →

How this article was generated

Generated
2 Nov 2026, 04:39
Data as of
2 Nov 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.